IR LIBRARY News & Press Releases 03/02 IR Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use 02/25 IR (Progress of Matters Previously Disclosed) Status of Discussions Toward Execution of a License Agreement with Laboratoires KÔL regarding Emixustat Hydrochloride, a Treatment Candidate for Stargardt Disease, at a Consolidated Subsidiary, Kubota Vision Inc. 02/24 IR [Delayed] FY2025 Results Briefing Material 02/24 IR [Delayed] Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (under IFRS) more info For information on SEC filings, please visit U.S. SEC's EDGAR service. CEO Message Company Financials SEC Filings Shareholders Meeting IR News Corporate Governance Financial Events Calendar FAQs Email Alerts
